Know Cancer

or
forgot password

Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma.


N/A
18 Years
N/A
Open (Enrolling)
Both
Melanoma

Thank you

Trial Information

Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma.


Inclusion Criteria:



- Patients > or = 18 years

- Patients with advanced melanoma stage IIIC (unresectable) or stage IV

- Patient not treated or not responding to chemotherapy with chemotherapy session last>
1 month

- Patients who signed informed consent

- Patients presenting no socio-economic, psychological, familial or geographical allow
proper understanding of the information leaflet of the protocol or the regular
monitoring in the department of dermatology

- Patients with a life expectancy greater than 3 months

- Patients with melanoma measurable by RECIST version 1.1

- Patients with venous good for venipuncture

Exclusion Criteria:

- Patients with contraindication for treatment with chemotherapy or V600E BRAF
inhibitor or ipilimumab or have conditions concomitant heavy may interfere with the
treatment of metastatic melanoma

- Pregnant women or nursing

- People vulnerable detainees, adults under guardianship or curatorship, minors.

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Measuring the number of circulating melanoma cells/ml in blood

Outcome Description:

Measuring the number of circulating melanoma cells/ml in the peripheral blood by the test before and after treatment CellSearch.

Outcome Time Frame:

baseline and 3 months

Safety Issue:

No

Principal Investigator

Damien GIACCHERO, PH

Investigator Role:

Study Director

Investigator Affiliation:

CHU de Nice

Authority:

France: Committee for the Protection of Personnes

Study ID:

11-AOI-04

NCT ID:

NCT01573494

Start Date:

May 2012

Completion Date:

May 2014

Related Keywords:

  • Melanoma
  • Cancer
  • Melanoma
  • Circulating Tumor Cells
  • Melanoma
  • Neoplastic Cells, Circulating

Name

Location